Makary Resigns as FDA Commissioner Following Policy Disputes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

  • 1

    Marty Makary resigned as FDA Commissioner after 13 months, with Kyle Diamantas appointed as acting commissioner.

  • 2

    Makary's tenure included workforce reductions and significant turnover among senior FDA officials.

  • 3

    He opposed pediatric mask and vaccine mandates during the COVID-19 pandemic, criticizing CDC data reliance.

  • 4

    Makary focused on vaccine policy, food additive regulation, and dietary guidance, advocating for reduced processed food intake.

  • 5

    His resignation followed tensions over telehealth prescribing, regulatory review consistency, and flavored vaping product authorizations.

Original Source(s)

Makary Resigns as FDA Commissioner Following Policy Disputes

  • by Kathryn Wighton

  • May 12, 2026

Related Content

Menstrual Fluid May Aid in Endometriosis Detection

Single-nucleus sequencing of menstrual fluid identified epithelial gene signatures and prioritized five candidate biomarkers that warrant validation in larger studies.

PTSD May Be Linked to Accelerated Aging

Integrated proteomic and metabolomic analyses identified redox-metabolic signatures associated with chronic posttraumatic stress disorder and accelerated biological aging across multiple organ systems.

NEJM Retracts Avacopan Vasculitis Study

"The primary end-point assessments in nine patients were readjudicated after database lock and trial unblinding"